MIB Guides: Preclinical Radiopharmaceutical Dosimetry

Area of Science:

• Nuclear Medicine
• Radiopharmaceutical Science
• Preclinical Research

Background:

• Preclinical dosimetry is vital for designing and evaluating animal studies involving radiopharmaceuticals.
• It ensures ethical animal research and provides initial human dose estimates for clinical translation.
• Accurate dosimetry supports the development of novel radiopharmaceutical therapies and imaging agents.

Purpose of the Study:

• To provide a basic protocol for obtaining preclinical dosimetry estimates.
• To guide researchers in using organ-level dosimetry software for animal studies.
• To facilitate the clinical translation of new radiopharmaceuticals by establishing initial human organ dose estimates.

Main Methods:

• The study outlines a protocol for preclinical dosimetry estimation.
• Utilizes organ-level dosimetry software for data analysis.
• Focuses on practical application in animal research settings.

Main Results:

• The MIB Guide presents a standardized protocol for preclinical dosimetry.
• Enables estimation of organ doses in animal models.
• Provides a foundation for human dose estimations.

Conclusions:

• Implementing this protocol enhances the reliability of preclinical radiopharmaceutical studies.
• Facilitates the ethical and effective translation of radiopharmaceuticals to clinical use.
• Organ-level dosimetry software is a key tool for accurate preclinical dose assessment.